The interplay of drug therapeutics and immune responses to SARS-CoV-2

被引：5
|
作者：
Fumagalli, Valeria [1 ,2 ]
Iannacone, Matteo [1 ,2 ,3 ]
机构：
[1] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Milan, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
[3] IRCCS San Raffaele Sci Inst, Expt Imaging Ctr, Milan, Italy
来源：
CELLULAR & MOLECULAR IMMUNOLOGY | 2024年 / 21卷 / 02期
基金：
欧洲研究理事会;
关键词：
SARS-CoV-2; Nirmatrelvir; Bisphosphonates; Adaptive immunity; Drug repurposing; ZOLEDRONIC ACID; BISPHOSPHONATE THERAPY; CELLS; MECHANISMS; MONOCYTES; SAFETY;
D O I：
10.1038/s41423-023-01098-7
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The SARS-CoV-2 pandemic has necessitated rapid therapeutic and preventative responses. While vaccines form the frontline of defense, antiviral treatments such as nirmatrelvir have emerged as vital adjunctive measures, particularly for those unable or unwilling to be vaccinated. This review delves into the potential influence of nirmatrelvir on enduring immunity. In parallel, the potential of drug repurposing is explored, with bisphosphonates being examined for their possible effects against COVID-19 due to their immunomodulatory properties. The importance of rigorous clinical trials and careful interpretation of preliminary data is emphasized.
引用
收藏
页码：197 / 200
页数：4
相关论文
共 50 条
  • [31] Diamond Light Source: contributions to SARS-CoV-2 biology and therapeutics
    Walsh, Martin A.
    Grimes, Jonathan M.
    Stuart, David I.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 538 : 40 - 46
  • [32] The Immune Response to SARS-CoV-2 and Variants of Concern
    Torbati, Elham
    Krause, Kurt L.
    Ussher, James E.
    VIRUSES-BASEL, 2021, 13 (10):
  • [33] Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
    Aherfi, Sarah
    Pradines, Bruno
    Devaux, Christian
    Honore, Stephane
    Colson, Philippe
    La Scola, Bernard
    Raoult, Didier
    FUTURE MICROBIOLOGY, 2021, 16 (17) : 1341 - 1370
  • [34] Reassuring humoral and cellular immune responses to SARS-CoV-2 vaccination in participants with systemic sclerosis
    Benoit, Jenna M.
    Breznik, Jessica A.
    Huynh, Angela
    Cowbrough, Braeden
    Baker, Barbara
    Heessels, Lauren
    Lodhi, Sumiya
    Yan, Elizabeth
    Bhakta, Hina
    Clare, Rumi
    Nazy, Ishac
    Bramson, Jonathan L.
    Larche, Maggie J.
    Bowdish, Dawn M. E.
    IMMUNOLOGY LETTERS, 2024, 270
  • [35] Characteristics of SARS-CoV-2 and Opisthorchis viverrini coinfections: insights into immune responses and clinical outcomes
    Charoensuk, Lakhanawan
    Pinlaor, Somchai
    Nimala, Boonpeng
    Suttiprapa, Sutas
    Prakobwong, Suksanti
    PARASITOLOGY RESEARCH, 2024, 123 (08)
  • [36] Immune responses and pathogenesis in persistently PCR-positive patients with SARS-CoV-2 infection
    Yu, Hai-bin
    Wang, Wen-jing
    Tang, Shan
    Chen, De-xi
    Xu, Bin
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (02) : 760 - 765
  • [37] Vitamin D Immune-Mediated Responses and SARS-CoV-2 Infection: Clinical Implications in COVID-19
    Gotelli, Emanuele
    Paolino, Sabrina
    Soldano, Stefano
    Cutolo, Maurizio
    IMMUNO, 2022, 2 (01): : 1 - 12
  • [38] Host Immune Response Driving SARS-CoV-2 Evolution
    Wang, Rui
    Hozumi, Yuta
    Zheng, Yong-Hui
    Yin, Changchuan
    Wei, Guo-Wei
    VIRUSES-BASEL, 2020, 12 (10):
  • [39] SARS-CoV-2 evades immune detection in alveolar macrophages
    Dalskov, Louise
    Mohlenberg, Michelle
    Thyrsted, Jacob
    Blay-Cadanet, Julia
    Poulsen, Ebbe Toftgaard
    Folkersen, Birgitte Holst
    Skaarup, Soren Helbo
    Olagnier, David
    Reinert, Line
    Enghild, Jan Johannes
    Hoffmann, Hans Jurgen
    Holm, Christian Kanstrup
    Hartmann, Rune
    EMBO REPORTS, 2020, 21 (12)
  • [40] Immunomodulators and SARS-CoV-2: Management of the Dysregulated Immune Response
    Thimmaiah, Chandramoull Mandya
    Hosmane, Giridhar Belur
    Behera, Debasis
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2023, 17 (04) : OE1 - OE8
12345